NOXXON Pharma AG announces management changes

CEO Dr Frank Morich will leave the company

30-Jun-2010 - Germany

NOXXON Pharma AG announced that CEO Dr Frank Morich will leave the company effective August 15, 2010 to take up the position Executive Vice President, International Operations, at Takeda Pharmaceutical Company Limited.

Iain Buchanan, who worked with the Board of Directors since 2007 and later became a Director of NOXXON Pharma AG, will assume the role of Interim CEO with effect from September 1, 2010, and will support the board during its search for a permanent replacement.

Iain has a track record and brings to NOXXON over 30 years of experience in the pharmaceutical and biotech industry. He comes to NOXXON from Novexel in Paris where, earlier this year, he was responsible for the sale of the company to Astra Zeneca. Prior to his role as CEO of Novexel Iain has held a range of management and business development positions within a number of companies in the pharmaceutical industry including Vertex, Johnson and Johnson, Biogen, and Merck & Co.

Other news from the department people

Most read news

More news from our other portals

So close that even
molecules turn red...